« Congressman Bob Good pushes Life at Conception Act Late on returning library books? That’s no longer a problem »
Roanoke-based Chorda Pharma moves toward product release with grant Published June 27, 2022 | By Gene Marrano Chorda Pharma, a local pharmaceutical company looking to bring its first product, Capsadyn – an over the counter medication for chronic pain to market next year – has received an important grant from the Commonwealth Commercialization Fund. LinkedinGoogleTwitterFacebook